Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Recruitment Status

Not yet recruiting clinical trials

Status pages show live ClinicalTrials.gov search results by recruitment status, with direct links to official study records plus page-level filtering and sorting.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 8:17 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials
3236
Shown on this page
12
Current sort
Recently updated
Status scope
Not yet recruiting
Additional filters apply within this recruitment status.

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

Filter and sort this status page

These controls apply only within Not yet recruiting. Default order is Recently updated. Add condition, location, sponsor, or therapy filters to narrow this status page further.

Reset status filters
Clear filters
Showing 109–120 of 3,236 matching trials with status Not yet recruiting.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.

Live official records

Open in full search
Not yet recruiting Phase 1 Interventional

TEA Synchronized With Natural Breathing for EPS

NCT07917598
View directory record Official record
Conditions
Epigastric Pain Syndrome
Interventions
AutoSTEA device, Sham treatment
Device
Lead sponsor
MetroHealth Medical Center
Other
Eligibility
18 Years and older
Enrollment
40 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2027 – 2030
U.S. locations
2
States / cities
Cleveland, Ohio • Parma, Ohio
Source: ClinicalTrials.gov public record
Updated Nov 4, 2026 · Synced Nov 5, 2026, 8:17 AM EST
Not yet recruiting Not applicable Interventional

Characterizing Tumor Hypoxia With BOLD-MRI to Predict Y-90 Treatment Response

NCT07916376
View directory record Official record
Conditions
Hepatocellular Carcinoma, Liver Cancer
Interventions
Blood oxygen level-dependent (BOLD) magnetic resonance imaging ( MRI)
Diagnostic Test
Lead sponsor
UNC Lineberger Comprehensive Cancer Center
Other
Eligibility
18 Years and older
Enrollment
12 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2027
U.S. locations
1
States / cities
Chapel Hill, North Carolina
Source: ClinicalTrials.gov public record
Updated Nov 4, 2026 · Synced Nov 5, 2026, 8:17 AM EST
Not yet recruiting Phase 2 Interventional

Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma

NCT07059611
View directory record Official record
Conditions
Gastric Adenocarcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Interventions
RP2, 5-Fluorouracil, Leucovorin, Oxaliplatin, Docetaxel, Pegfilgrastim, Filgrastim, Surgical Resection of Primary Tumor
Biological · Combination Product · Drug + 1 more
Lead sponsor
Abramson Cancer Center at Penn Medicine
Other
Eligibility
18 Years and older
Enrollment
34 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2027 – 2029
U.S. locations
1
States / cities
Philadelphia, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Nov 4, 2026 · Synced Nov 5, 2026, 8:17 AM EST
Not yet recruiting Not applicable Interventional

POSLUMA PET Imaging for PI-RADS 3 Prostate Lesions

NCT07916311
View directory record Official record
Conditions
Prostate Cancer, PI-RADS 3 Prostate Lesion
Interventions
PET Imaging with Flotufolastat F 18
Diagnostic Test
Lead sponsor
SimonMed Imaging
Other
Eligibility
18 Years and older · Male only
Enrollment
130 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2028
U.S. locations
6
States / cities
Avondale, Arizona • Chandler, Arizona • Mesa, Arizona + 3 more
Source: ClinicalTrials.gov public record
Updated Nov 4, 2026 · Synced Nov 5, 2026, 8:17 AM EST
Not yet recruiting Not applicable Interventional

Adapting the "Do More, Feel Better" Intervention for Older People Living With HIV

NCT07915934
View directory record Official record
Conditions
Depression, HIV
Interventions
"Do More, Feel Better" for Older People with HIV
Behavioral
Lead sponsor
University of Washington
Other
Eligibility
50 Years and older
Enrollment
48 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2027 – 2028
U.S. locations
1
States / cities
Seattle, Washington
Source: ClinicalTrials.gov public record
Updated Nov 4, 2026 · Synced Nov 5, 2026, 8:17 AM EST
Not yet recruiting Not applicable Interventional

COG+OT Telerehabilitation for Adults With Subjective Cognitive Complaints

NCT07743229
View directory record Official record
Conditions
Subjective Cognitive Complaints, Ehlers-Danlos Syndrome, Cognitive Dysfunction
Interventions
COG+OT Telerehabilitation
Behavioral
Lead sponsor
Medical University of South Carolina
Other
Eligibility
18 Years to 99 Years
Enrollment
16 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2027
U.S. locations
2
States / cities
Charleston, South Carolina
Source: ClinicalTrials.gov public record
Updated Nov 4, 2026 · Synced Nov 5, 2026, 8:17 AM EST
Not yet recruiting Not applicable Interventional

Parent-Based Intervention for Childhood Avoidant/Restrictive Food Intake Disorder (ARFID)

NCT07916974
View directory record Official record
Conditions
Anxiety Disorder of Adolescence, Avoidant / Restrictive Food Intake Disorder
Interventions
Supportive Parenting for Anxious Childhood Emotions (SPACE), Nutritional Support (NS)
Behavioral
Lead sponsor
Yale University
Other
Eligibility
6 Years to 12 Years
Enrollment
110 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2030
U.S. locations
1
States / cities
New Haven, Connecticut
Source: ClinicalTrials.gov public record
Updated Nov 4, 2026 · Synced Nov 5, 2026, 8:17 AM EST
Not yet recruiting Phase 1 Interventional

A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

NCT06941480
View directory record Official record
Conditions
Neuroendocrine Tumor of the Lung, Neuroendocrine Carcinoma of Lung, Neuroendocrine Carcinoma, Neuroendocrine Carcinoma of Prostate
Interventions
PET/CT, 177Lu-DTPA-SC16.56
Diagnostic Test · Biological
Lead sponsor
Memorial Sloan Kettering Cancer Center
Other
Eligibility
18 Years and older
Enrollment
12 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2030
U.S. locations
7
States / cities
Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more
Source: ClinicalTrials.gov public record
Updated Nov 4, 2026 · Synced Nov 5, 2026, 8:17 AM EST
Not yet recruiting Phase 2 Interventional

REducing Systemic Inflammation With LOw-dose Colchicine to ImproVE Cardiovascular Calcification in Chronic Kidney Disease: A Pilot Randomized Open-Label Trial

NCT07654231
View directory record Official record
Conditions
Chronic Kidney Disease Mineral and Bone Disorder, Cognitive Function, Vascular Calcification, Coronary Artery Calcification, Mineral and Bone Disorder (CKD-MBD), Peripheral Arterial Disease, Systemic Inflammation, Chronic Kidney Disease
Interventions
Low-dose Colchicine at 0.5mg daily, Usual Care
Drug · Other
Lead sponsor
University of Texas Southwestern Medical Center
Other
Eligibility
30 Years to 69 Years
Enrollment
60 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2029
U.S. locations
1
States / cities
Dallas, Texas
Source: ClinicalTrials.gov public record
Updated Nov 4, 2026 · Synced Nov 5, 2026, 8:17 AM EST
Not yet recruiting Phase 1 Interventional Accepts healthy volunteers

Brain Dopamine Dynamics in Obesity

NCT07915986
View directory record Official record
Conditions
Obesity
Interventions
Milkshake, NeuroEXPLORER, [11C]raclopride
Other · Device · Drug
Lead sponsor
Yale University
Other
Eligibility
50 Years to 65 Years
Enrollment
100 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2026 – 2029
U.S. locations
1
States / cities
New Haven, Connecticut
Source: ClinicalTrials.gov public record
Updated Nov 4, 2026 · Synced Nov 5, 2026, 8:17 AM EST
Not yet recruiting Phase 3 Interventional

Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis

NCT07916480
View directory record Official record
Conditions
Atopic Dermatitis, Atopic Dermatitis (AD), Atopic Dermatitis (Eczema)
Interventions
Roflumilast Cream 0.3%, Vehicle Cream
Drug
Lead sponsor
Arcutis Biotherapeutics, Inc.
Industry
Eligibility
6 Years and older
Enrollment
415 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2029
U.S. locations
1
States / cities
Chicago, Illinois
Source: ClinicalTrials.gov public record
Updated Nov 4, 2026 · Synced Nov 5, 2026, 8:17 AM EST
Not yet recruiting Phase 1Phase 2 Interventional

Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2 (iSPASM-2)

NCT07493577
View directory record Official record
Conditions
Aneurysmal Subarachnoid Hemorrhage
Interventions
Tirofiban, Placebo
Drug
Lead sponsor
Dr David Hasan, M.D.
Other
Eligibility
18 Years to 85 Years
Enrollment
82 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2032
U.S. locations
2
States / cities
Durham, North Carolina • Houston, Texas
Source: ClinicalTrials.gov public record
Updated Nov 4, 2026 · Synced Nov 5, 2026, 8:17 AM EST